These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation. Kang YK, Kang BW, Im SA, Lee JL, Park SR, Kang WK, Chang HM, Kim TW, Oh DY, Jung KH, Ryu MH. Cancer Chemother Pharmacol; 2013 Jan; 71(1):43-51. PubMed ID: 23053257 [Abstract] [Full Text] [Related]
28. Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a case. Ando Y, Tsunoda T, Beck Y, Takayama T, Tahara H. Surg Today; 2005 Jan; 35(2):157-60. PubMed ID: 15674500 [Abstract] [Full Text] [Related]
33. [Two cases of surgical resection of rectal gastrointestinal stromal tumor after neoadjuvant therapy with imatinib mesylate]. Nakashima S, Fujita Y, Matsuo H, Ariyoshi Y, Fukuda K, Fujiyama J, Masuyama M. Gan To Kagaku Ryoho; 2012 Nov; 39(12):1932-4. PubMed ID: 23267934 [Abstract] [Full Text] [Related]
35. [No recurrent case of the combination of surgical management with chemotherapy]. Hasegawa H, Harada A, Kitagawa D, Nakamura T, Kondo N, Shoji F, Kabashima A, Teramoto S, Funahashi W, Ikeda Y. Gan To Kagaku Ryoho; 2014 Nov; 41(12):2475-7. PubMed ID: 25731562 [Abstract] [Full Text] [Related]